Global Healthcare Advisors, LLC (“GHA”) is pleased to announce the acquisition of Canada’s Dalton Pharma Services (“Dalton”) by Japan’s Seikagaku Corporation (“SKK”). With the acquisition of Dalton, SKK adds high value-added one-stop contract development and manufacturing (“CDMO”) services, including the manufacturing of chemosynthesis products and active pharmaceutical ingredients (“API”), and API process development for pharmaceutical companies at a time of strong industry growth. Dalton’s services also include the manufacturing of investigational drugs in the development stage and optimization of manufacturing conditions.
Read the full article: GHA Advises Seikagaku on Its Acquisition of Dalton Pharma Services //
Source: https://mailchi.mp/ghadvisors/gha-advises-seikagaku-on-its-acquisition-of-dalton-chemical-laboratories-534969